How To Know If Cns Pharmaceuticals Inc (NASDAQ:CNSP) Is Expensive At $6.99.

In recent trading session, Cns Pharmaceuticals Inc (NASDAQ:CNSP) saw 2.9 million shares changing hands at last check today with its beta currently measuring 1.13. Company’s recent per share price level of $6.99 trading at $3.37 or 93.09% at last check today assigns it a market valuation of $1.68M. That most recent trading price of CNSP’s stock is at a discount of -1867.1% from its 52-week high price of $137.50 and is indicating a premium of 56.22% from its 52-week low price of $3.06. Taking a look at company’s average trading volume volume of 30.04K if we extend that period to 3-months.

Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information

Upright in the green today for gaining 93.09%, in the last five days CNSP remained trading in the green while hitting it’s week-highest on Friday, 06/14/24 when the stock touched $6.99 price level, adding 1.13% to its value on the day. Cns Pharmaceuticals Inc’s shares saw a change of -88.99% in year-to-date performance and have moved 38.42% in past 5-day. Cns Pharmaceuticals Inc (NASDAQ:CNSP) showed a performance of -29.96% in past 30-days.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Cns Pharmaceuticals Inc (CNSP) estimates and forecasts

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 17.98% during past 5 years.

CNSP Dividends

Cns Pharmaceuticals Inc is more likely to be releasing its next quarterly report in July and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.